Expression of CRF1 and CRF2 receptors in human cancers

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 7, 2003, Pages 3312-3320

  Reubi, Jean Claude ^a   Waser, Beatrice ^a   Vale, Wylie ^b   Rivier, Jean ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; IODINE 125; RADIOLIGAND; RECEPTOR SUBTYPE; SAUVAGINE; UNCLASSIFIED DRUG; UROCORTIN;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CORTICOTROPIN RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENINGIOMA; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; NONHUMAN; PANCREAS TUMOR; PARAGANGLIOMA; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ADENOMA; AUTORADIOGRAPHY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NERVOUS SYSTEM NEOPLASMS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PITUITARY NEOPLASMS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0037622756     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021853     Document Type: Article

References (49)

1. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC 1995 Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear medicine annual 1995. New York: Raven Press; 1-50
2. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Yang Q, Radosavljevic M, Leimer M, Kaserer K, Li SR, Kornek G, Hübsch P, Niederle B, Pidlich J, Scheithauer W, Valent P 1996 123-I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract. Nucl Med Biol 23:685-692
3. Behr TM, Jenner N, Behe M, Angerstein C, Gratz S, Raue F, Becker W 1999 Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J Nucl Med 40:1029-1044
4. Van de Wiele C, Dumont F, Vanden Broecke R, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thornback J, Slegers G, Dierckx RA 2000 Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study. Eur J Nucl Med 27:1694-1699
5. Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, De Cicco C, Macke HR, Chinol M, de Braud F 2001 Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide. Eur J Nucl Med 28:426-434
6. Otte A, Herrmann R, Heppeler A, Behe M, Jermann E, Powell P, Maecke HR, Muller J 1999 Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med 26:1439-1447
7. Krenning EP, de Jong M, Kooij PP, Breeman WA, Bakker WH, de Herder WW, van Eijck CH, Kwekkeboom DJ, Jamar F, Pauwels S, Valkema R 1999 Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol 10:S23-S29
8. Reubi JC, Gugger M, Waser B, Schaer JC 2001 Y1-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res 61:4636-4641
9. Reubi JC, Waser B, Schaer JC, Laissue JA 2001 Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 28:836-846
10. Reubi JC, Läderach U, Waser B, Gebbers J-O, Robberecht P, Laissue JA 2000 Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 60:3105-3112
11. Markwalder R, Reubi JC 1999 Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res 59:1152-1159
12. Reubi JC, Waser B, Friess H, Büchler MW, Laissue JA 1998 Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut 42:546-550
13. Reubi JC, Schaer JC, Waser B 1997 Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57:1377-1386
14. Schally AV 1988 Oncological applications of somatostatin analogs. Cancer Res 48:6977-6985
15. Zia H, Hida T, Jakowlew S, Birrer M, Gozes Y, Reubi JC, Fridkin M, Gozes I, Moody TW 1996 Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist. Cancer Res 56:3486-3489
16. Moody TW, Venugopal R, Zia R, Patierno S, Leban JJ, McDermed J 1995 BW2258U89: a GRP antagonist which inhibits small cell lung cancer. Life Sci 56:521-529
17. Reubi JC, Laissue JA 1995 Multiple pathways of somatostatin action in neoplastic disease. Trends Pharmacol Sci 16:110-115
18. Dunn AJ, Berridge CW 1990 Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15:71-100
19. De Souza EB, Grigoriadis DE 1994 Corticotropin-releasing factor: Physiology, pharmacology and role in central nervous system and immune disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 505-517
20. Parkes DG, Weisinger RS, May CN 2001 Cardiovascular actions of CRH and urocortin: an update. Peptides 22:821-827
21. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Vale WW, Lee KF 2002 Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA 99:7734-7739
22. Graziani G, Tentori L, Portarena I, Barbarino M, Tringali G, Pozzoli G, Navarra P 2002 CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway. Endocrinology 143:807-813
23. Tjuvajev J, Kolesnikov Y, Joshi R, Sherinski J, Koutcher L, Zhou Y, Matei C, Koutcher J, Kreek MJ, Blasberg R 1998 Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo 12:1-10
24. Grigoriadis DE, Lovenberg TW, Chalmers DT, Liaw C, De Souze EB 1996 Characterization of corticotropin-releasing factor receptor subtypes. Ann N Y Acad Sci 780:60-80
25. De Souza EB, Grigoriadis DE 2000 Multiple brain corticotropin-releasing factor receptors and binding protein. In: Quirion R, Björklund A, Hökfelt T, eds. Handbook of chemical neuroanatomy. Vol 16. Amsterdam: Elsevier Science BV; 477-508
26. Florio P, Franchini A, Reis FM, Pezzani I, Ottaviani E, Petraglia F 2000 Human placenta, chorion, anmion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta 21:32-37
27. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H 2002 Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87:340-346
28. Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Hongo M, Oki Y, Sasano H 2001 Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. J Clin Endocrinol Metab 86:1362-1369
29. Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H 2000 Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa. Peptides 21:1799-1809
30. Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R 1999 Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system"? Ann N Y Acad Sci 885:287-311
31. Dieterich KD, DeSouza EB 1996 Functional corticotropin-releasing factor receptors in human neuroblastoma cells. Brain Res 733:113-118
32. Dieterich KD, Grigoriadis DE, De Souza EB 1994 Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data. Endocrinology 135:1551-1558
33. Funasaka Y, Sato H, Chakraborty AK, Ohashi A, Chrousos GP, Ichihashi M 1999 Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J Investig Dermatol Symp Proc 4:105-109
34. Schoeffter P, Feuerbach D, Bobirnac I, Gazi L, Longato R 1999 Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells. Fundam Clin Pharmacol 13:484-489
35. Dieterich KD, Gundelfinger ED, Ludecke DK, Lehnert H 1998 Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 83:3327-3331
36. Grino M, Guillaume V, Boudouresque F, Margioris AN, Grisoli F, Jaquet P, Oliver C, Conte-Devolx B 1988 Characterization of corticotropin-releasing hormone receptors on human pituitary corticotroph adenomas and their correlation with endogenous glucocorticoids. J Clin Endocrinol Metab 67:279-283
37. Sakai Y, Horiba N, Sakai K, Tozawa F, Kuwayama A, Demura H, Suda T 1997 Corticotropin-releasing factor up-regulates its own receptor gene expression in corticotropic adenoma cells in vitro. J Clin Endocrinol Metab 82:1229-1234
38. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Tache Y, Vale W 2002 Potent and long acid corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45:4737-4747
39. De Souza EB, Kuhar MJ 1986 Corticotropin-releasing factor receptors in the pituitary gland and central nervous system: methods and overview. Methods Enzymol 124:560-590
40. Rivier J, Gulyas J, Kirby D, Kunitake K, DiGruccio M, Donaldson C, Vaughan J, Perrin MH, Koerber SC, Martinez V, Tache Y, Wang L, Rivier C, Vale W 2001 Receptor-selective corticotropin releasing factor analogs. Proc 31st Annual Meeting of the Society for Neuroscience, San Diego, CA, pp 413-417 (Abstract 413.17)
41. Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW 1999 Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther 288:729-734
42. Denzler B, Reubi JC 1999 Expression of somatostatin receptors in peritumoral veins of human tumors. Cancer 85:188-198
43. Arcuri F, Cintorino M, Florio P, Floccari F, Pergola L, Romagnoli R, Petraglia F, Tosi P, Teresa Del Vecchio M 2002 Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma. Prostate 52:167-172
44. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971
45. Lopes MBS 2000 Tumors of the pituitary gland. In: Fletcher CDM, ed. Diagnostic histopathology of tumors. London: Churchill Livingstone; 931-957
46. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C 1996 Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 56:1823-1827
47. Gugger M, Reubi JC 1999 GRP receptors in non-neoplastic and neoplastic human breast. Am J Pathol 155:2067-2076
48. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A, Genazzani AR, Petraglia F 1999 Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 84:2802-2806
49. Sanz E, Monge L, Fernandez N, Martinez MA, Martinez-Leon JB, Dieguez G, Garcia-Villalon AL 2002 Relaxation by urocortin of human saphenous veins. Br J Pharmacol 136:90-94